Research Journal of Pharmacology and Pharmacodynamics

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Corticosteroids and Way of Inflammation


Affiliations
1 R.R.K.College of Pharmacy, Bidar, Karnataka, India
2 K.L.E. College of Pharmacy, Hubli, Karnataka, India
     

   Subscribe/Renew Journal


No Abstract.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Abbinante-Nissen, J. M., Simpson, L. G. and Leikauf, G. D. (1995). Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. phys. 268.

  • Adcock, I. M. and Caramori, G. (2001). Cross-talk between proinflammatory transcription factors and glucocorticoids. Immunology and Cell Biology 79, 376-384.

  • Adcock, I. M., Nasuhara, Y., Stevens, D. A. and Barnes, P. J. (1999). Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. Br J Pharmacol 127, 1003-11.

  • Adcock, I. M., Newton, R. and Barnes, P. J. (1997). NF-kappa B involvement in IL-1 beta-induction of GM-CSF and COX-2: inhibition by glucocorticoids does not require I-kappa B. Biochem Soc Trans 25, 154s.

  • Amrani, Y., Lazaar, A. L. and Panettieri, R. A. J. (1999). Up-regulation of ICAM-1 by cytokines in human tracheal smooth muscle cells involves an NF-kappa B-dependent signaling pathway that is only partially sensitive to dexamethasone. J. Immunol. 163, 2128-2134.

  • Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A. and Karin, M. (1995). Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270, 286-90.

  • Balsalobre, A., Brown, S. A., Marcacci, L., Tronche, F., Kellendonk, C., Reichardt, H. M., Schütz, G. and Schnibler U. (2000). Resetting of circadian time in peripheral tissues by glucocorticoid signalling. Science 289, 2344-2347.

  • Barnes, P. J. (1998). Anti-inflammatory actions of glucocorticoids: molecular mechanisms [editorial]. Clin Sci Colch 94, 557-72.

  • Barnes, P. J. and Adcock, I. M. (1997). NF-kappa B: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci 18, 46-50.

  • Barnes, P. J., Greening, A. P. and Crompton, G. K. (1995). Glucocorticoid resistance in asthma. Am J Respir Crit Care Med 152, s125-40.

  • Barnes, P. J. and Karin, M. (1997). Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N.Engl.J.Med 336, 1066-1071.

  • Beato, M. (1989). Gene regulation by steroid hormones. Cell 56, 335-344.

  • Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. and Baltimore, D. (1995). Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376, 167-170.

  • Beyaert, R. (1999). NF-kappa B as an emerging target in atopy. Emerging Therapeutic Targets 3.

  • Beyaert, R., Suffys, P., Van Roy, F. and Fiers, W. (1990). Inhibition by glucocorticoids of tumor necrosis factor-mediated cytotoxicity. Evidence against lipocortin involvement. FEBSLetters 262, 93-96.

  • Boumpas, D. T., Chrousos, G. P., Wilder, R. L., Cupps, T. R. and Balow, J. E. (1993). Glucocorticoid therapy for immunemediated diseases: basic and clinical correlates. Ann Intern Med 119, 1198-208.

  • Brostjan, C., Anrather, J., Csizmadia, V., Stroka, D., Soares, M., Bach, F. H. and Winkler, H. (1996). Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem 271, 19612-19616.

  • Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., bonn, T., Engstrom, O., Ohman, L., Greene, G. L., Gustafsson, J. A. and Carlquist, M. (1998). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758.

  • Burke, L. J. and Baniahmad, A. (2000). Corepressors. FASEB J. 14, 1876-1888.

  • Caelles, C., Gonzalez Sancho, J. M. and Munoz, A. (1997). Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 11, 3351-3364.

  • Caldenhoven, E., Liden, J., Wissink, S., Van de Stolpe, A., Raaijmakers, J., Koenderman, L., Okret, S., Gustafsson, J. A. and Van der Saag, P. T. (1995). Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9, 401-12.

  • Cato, A. C. and Wade, E. (1996). Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 18, 371-8.

  • Chakravarti, D., LaMorte, V. J., Nelson, M. C., Nakajima, T., Schulman, I. G., Juguilon, H., Montminy, M. and Evans, R. M. (1996). Role of CBP/P300 in nuclear receptor signalling. Nature 383, 99-103.

  • Chaudhary, L. R. and Avioli, L. V. (1996). Regulation of interleukin-8 gene expression by interleukin-1beta, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells. J Biol Chem 271, 16591-6.

  • De Bosscher, K., Schmitz, M. L., Vanden Berghe, W., Plaisance, S., Fiers, W. and Haegeman, G. (1997).Glucocorticoid-mediated repression of nuclear factor-kappaBdependent transcription involves direct interference with transactivation. Proc Natl Acad Sci U S A 94, 13504-13509.

  • De Bosscher, K., Vanden Berghe, W. and Haegeman, G.(2000a). Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J.Neuroimmunology 109, 16-22.

  • De Bosscher, K., Vanden Berghe, W. and Haegeman, G. (2001). Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Molecular Endocrinology 15, 219-227.

  • De Bosscher, K., Vanden Berghe, W., Vermeulen, L., Plaisance, S., Boone, E. and Haegeman., G. (2000b). Glucocorticoids repress NFkB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc. Natl. Acad. Sci. 97, 3919-3924.

  • De Kloet, E. R., Vreugdenhil, E., Oitzl, M. S. and Joels, M. (1998). Brain corticosteroid receptor balance in health and disease. Endocr Rev 19, 269-301.

  • De Vera, M. E., Taylor, B. S., Wang, Q., Shapiro, R. A., Billiar, T. R. and Geller, D. A. (1997). Dexamethasone suppresses iNOS gene expression by upregulating I-kappa B alpha and inhibiting NF-kappa B. Am J Physiol 273, g1290-6.

  • DeFranco, D. B. and Guerrero, J. (2000). Nuclear matrix targeting of steroid receptors: specific signal sequences and adaptor proteins. Crit. Rev. Eukaryot. Gene Expr. 10, 39-44.

  • Delany, A. M., Gabbitas, B. Y. and Canalis, E. (1995). Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms. J Cell Biochem 57, 488-94.

  • Doucas, V., Shi, Y., Miyamoto, S., West, A., Verma, I. and Evans, R. M. (2000). Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci 97, 11893-11898.

  • Doucas, V., Tini, M., Egan, D. A. and Evans, R. M. (1999). Modulation of CREB binding protein function by the promyelocytiv (PML) oncoprotein suggests a role for nuclear bodies in hormone signalling. Proc. Natl. Acad. Sci 96, 2627-2632.

  • Eggert, M., Mows, C. C., Tripier, D., Arnold, R., Michel, J., Nickel, J., Schmidt, S., Beato, M. and Renkawitz, R. (1995). A fraction enriched in a novel glucocorticoid receptor-interacting protein stimulates receptor-dependent transcription in vitro. J Biol Chem 270, 30755-9.

  • Francastel, C., Schubeler, D., Martin, D. I. and Groudine, M. (2000). Nuclear compartmentalization and gene activity. Nat. Rev. Mol. Cell Biol. 1, 137-143.

  • Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y. and Collins, T. (1997). CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U.S.A. 94, 2927-2932.

  • Hager, G. L., Lim, C. S., Elbi, C. and Baumann, C. T. (2000). TRafficking of nuclear receptors in living cells. J. Steroid Biochem. Mol. Biol. 74, 249-254.

  • Heck, S., Bender, K., Kullmann, M., Gottlicher, M., Herrlich, P. and Cato, A. C. (1997). I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J 16, 4698-707.

  • Heck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H. J., Herrlich, P. and Cato, A. C. (1994). A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 13, 4087-4095.

  • Helmberg, A., Auphan, N., Caelles, C. and Karin, M. (1995). Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. Embo J 14, 452-60.

  • Hinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C. and Strauss, M. (1999). NF-kappa B function in growth control: regulation of cyclin D expression and G0/G1-to-S-phase transition. Mol Cell Biol 19, 2690-2698.

  • Hofmann, T. G., Hehner, S. P., Bacher, S., Droge, W. and Schmitz, M. L. (1998). Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NFkappaB-dependent transcription. FEBS Lett 441, 441-6.

  • Horwitz, K. B., Jackson, T. A., Bain, D. I., Richer, J. K., Takimoto, G. K. and Tung, L. (1996). Nuclear receptor coactivators and corepressors. Mol Endocrinol 10, 1167-1177.

  • Ito, K., Barnes, P. J. and Adcock, I. M. (2000). Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits IL-1betainduced histone H4 acetylation on Lysines 8 and 12. Mol. Cell. Biol. 20, 6891-6903.

  • Ito, K., Jazrawi, E., Cosio, B., Barnes, P. J. and Adcock, I. M. (2001). p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex. J. Biol. Chem. 276, 30208-30215.

  • Jackson, T. A., Richer, J. K., Bain, D. L., Takimoto, G. S., Tung, L. and Horwitz, K. B. (1997). The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol Endocrinol 11, 693-705.

  • Jehn, B. M. and Osborne, B. A. (1997). Gene regulation associated with apoptosis. Crit. Rev. Eukaryot.Gene Expr. 7, 179-193.

  • Kaltschmidt, B., Kaltschmidt, C., Hehner, S. P., Droge, W. and Schmitz, M. L. (1999). Repression of NF-kappa B impairs HeLa cell proliferation by functional interference with cell cyclecheckpoint regulators. Oncogene 18.

  • Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S. C., Heyman, R. A., Rose, D. W., Glass, C. K. and Rosenfeld, M. G. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.

  • Karin, M. (1998). New twists in gene regulation byglucocorticoid receptor: is DNA binding dispensable? Cell 93, 487-490.

  • Kassel, O., Sancono, A., Kratzschmar, J., Kreft, B., Stassen, M. and Cato, C. B. (2001). Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 20, 7108-7116.

  • Kniyamu, H. K., Fryer, C. J., Horwitz, K. B. and Archer, T. K. (2000). The mouse mammary tumor virus promoter adopts distinct chromatin structures in hulan breast cancer cells with and without glucocorticoid receptor. J. Biol. Chem. 275, 20061-20068.

  • Korzus, E., Torchia, J., Rose, D. W., Xu, L., Kurokawa, R., McInerney, E. M., Mullen, T. M., Glass, C. K. and Rosenfeld, M. G. (1998). Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279, 703-707.

  • Lasa, M., Brook, M., Saklatvala, J. and Clark, R. A. (2001). Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol. Cell. Biol. 21, 771-780.

  • Lavinsky, R. M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T. M., Schiff, R., Del Rio, A. L., Ricote, M., Ngo, S., Gemsch, J., Hilsenbeck, S. G., Osborne, C. K., Glass, C. K., Rosenfeld, M. G. and Rose, D. W. (1998). Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci U S A 95, 2920-2925.

  • Lefstin, J. A. and Yamamoto, K. R. (1998). Allosteric effects of DNA on transcriptional regulators. Nature 392, 885-888.

  • Lemon, B., Inouye, C., King, D. S. and Tjian, R. (2001). selectivity of chromatin-remodelling cofactors for ligandactivated transcription. Nature 414, 924-928.

  • control. Genes Dev 14, 2551-2569.

  • Lezoualc'h, F., Sagara, Y., Holsboer, F. and Behl, C. (1998). High constitutive NF-kappaB activity mediates resistance to oxidative stress in neuronal cells. J Neurosci 18, 3224-32.

  • Liden, J., Delaunay, F., Rafter, I., Gustafsson, J. and Okret, S. (1997). A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation. J Biol Chem 272, 21467-72.

  • Liden, J., Rafter, I., Truss, M., Gustafsson, J. and Okret, S. (2000). Glucocorticoid effects on NF-kappa B binding in the transcription of the ICAM-1 gene. Biochem Biophys Res Commun 273, 1008-1014.

  • Ma, H., Baumann, C. T., Li, H., Strahl, B. D., Rice, R., Jelinek, M. A., Aswad, D. W., Allis, C. D. and Stallcup, M. R. (2001). hormonedependent, CARM1-directed, arginine-specific methylation of histone H3 on a steroid-regulated promoter. Curr Biol. 11, 1981-1985.

  • McEwan, I. J., Wright, A. P. and Gustafsson, J. A. (1997). Mechanism of gene expression by the glucocorticoid receptor: role of protein-protein interactions. Bioessays 19, 153-160. McKay, L. I. and Cidlowski, J. A. (1998). Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 12, 45-56.

  • Meyer, T., Carlstedt Duke, J. and Starr, D. B. (1997). A weak TATA box is a prerequisite for glucocorticoid-dependent repression of the osteocalcin gene. J Biol Chem 272, 30709-14.

  • Moras, D. and Gronemeyer, H. (1998). The nuclear receptor ligand-binding domain: structure and function. CURRENT.OPINION.IN CELL BIOLOGY. 10, 384-391.

  • Newton, R., Hart, L. A., Stevens, D. A., Bergmann, M., Donnelly, L. E., Adcock, I. M. and Barnes, P. J. (1998). Effect of dexamethasone on interleukin-1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells. Eur J Biochem 254, 81-9.

  • Nichols, M., Rientjes, J. M. and Stewart, A. F. (1998). Different positioning of the ligand-binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists. EMBO J 17, 765-73.

  • Nissen, R. M. and Yamamoto, K. R. (2000). The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 14, 2314-2329.

  • Onate, S. A., Tsai, S. Y., Tsai, M. J. and O'Malley, B. W. (1995). Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354-1357.

  • Oro, A. E., Hollenberg, S. M. and Evans, R. M. (1988). Transcriptional inhibition by a glucocorticoid receptor-betagalactosidasefusion protein. Cell 55, 1109-1114.

  • Perissi, V., Dasen, J. S., Kurokawa, R., Wang, Z. Y., Korzus, E., Rose, D. W., Glass, C. K. and Rosenfeld, M. G. (1999). Factorspecific modulation of CREB-binding protein acetyltransferase activity. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 96, 3652-3657.

  • Perkins, N. D. (1997). Achieving transcriptional specificity with NF-kB. Int J Biochem Cell Biol 29, 1433-1448.

  • Ramdas, J. and Harmon, J. M. (1998). Glucocorticoid-induced apoptosis and regulation of NF-kappaB activity in human leukemic T cells. Endocrinology 139, 3813-21.

  • Ray, K. P. and Searle, N. (1997). Glucocorticoid inhibition of cytokine-induced E-selectin promoter activation. Biochem Soc Trans 25, 189s.

  • Ray, P., Ghosh, S. K., Zhang, D. H. and Ray, A. (1997). Repression of interleukin-6 gene expression by 17 betaestradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 409, 79-85.

  • Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P. and Schutz, G. (1998). DNA binding of the glucocorticoid receptor is not essential for survival [see comments]. Cell 93, 531-541.

  • Reichardt, H. M., Tuckermann, J. P., Gottlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P. and Schütz, G. (2001). Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J 20, 7168-7173.

  • Resche-Rigon, M. and Gronemeyer, H. (1998). Therapeutic potential of selective modulators of nuclear receptor action. Curr. Op. Chem. Biol. 2, 501-507.

  • Scheinman, R., Cogswell, P. C., Lofquist, A. and Baldwin, A. S. (1995a). Role of transcriptional activation of i kappa b alpha in mediation of immunosuppression by glucocorticoids [see comments]. Science 270, 283-286.

  • Scheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A. and Baldwin, A. S., Jr. (1995b). Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol 15, 943-953.

  • Schmitz, M. L., Stelzer, G., Altmann, H., Meisterernst, M. and Baeuerle, P. A. (1995). Interaction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivators. J Biol Chem270, 7219-7226.

  • Sheppard, K.-A., Phelps, K. M., Williams, A. J., Thanos, D., Glass, C. K., Rosenfeld, M. G., Gerritsen, M. E. and Collins, T. (1998). Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J Biol Chem 273, 29291-4.

  • Sheppard, K.-A., Rose, D. W., Haque, Z. K., Kurokawa, R., McInerney, E., Westin, S., Thanos, D., Rosenfeld, M. G., Glass, C. K. and Collins, T. (1999). Transcriptional activation by NFkappa B requires multiple coactivators. Mol Cell Biol 19, 6367-6378.

  • Stenoien, D. L., Mancini, M. G., Patel, K., Allegretto, E. A., Smith, C. L. and Mancini, M. A. (2000). Subnuclear trafficking of estrogen receptor alpha and steroid receptor coactivator-1. Mol. Endocrinol. 15, 518-534.

  • Stewart, S. and Crabtree, G. R. (2000). Transcription. Regulation of the regulators. Nature 408, 46-47.

  • Swantek, J. L., Cobb, M. H. and Geppert, T. D. (1997). Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alfa (TNF-a) translation: glucocorticoids inhibit TNF-afla translation by blocking JNK/SAPK. Mol Cell Biol 17, 6274-6282.

  • Tao, Y., Williams-Skipp, C. and Scheinman, R. I. (2001). Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappaB and induction of apoptosis. J. Biol. Chem. 276.

  • Thiele, K., Bierhaus, A., Autschbach, F., Hofmann, M., Stremmel, W., Thiele, H., Ziegler, R. and Nawroth, P. P. (1999). Cell specific effects of glucocorticoid treatment on the NF-kappa Bp65/IkappaBalpha system in patients with Crohn's disease. Gut 45, 693-704.

  • Tobler, A., Meier, R., Seitz, M., Dewald, B., Baggiolini, M. and Fey, M. F. (1992). Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of MCSF in human fibroblasts. Blood 79, 45-51.

  • Unlap, M. T. and Jope, R. S. (1997). Dexamethasone attenuates NF-kappa B DNA binding activity without inducing I kappa B levels in rat brain in vivo. Brain Res Mol Brain Res 45, 83-9.

  • Urnov, F. D. and Wolffe, A. P. (2001). A necessary good: nuclear hormone receptors and their chromatin template. Mol. Endocrinol. 15, 1-16.

  • Vanden Berghe, W., De Bosscher, K., Plaisance, S., Boone, E. and Haegeman, G. (1999a). The Nuclear Factor-kappa B engages CBP/p300 and Histone Acetyltransferase Activity for Transcriptional Activation of the Interleukin-6 Gene Promoter. J Biol Chem 274, 32091-32098.

  • Vanden Berghe, W., De Bosscher, K., Vermeulen, L., De Wilde, G. and Haegeman, G. (2002). Induction and repression of NF-kappa B driven inflammatory genes. Springer-Verlag Series In Press.

  • Vanden Berghe, W., Francesconi, E., De Bosscher, K., Rèsche-Rigon, M. and Haegeman, G. (1998). Dissociated Glucocorticoids with Antiinflammatory Potential Repress Interleukin-6 Gene Expression by an NF-kappa-B-Dependent Mechanism. submitted .

  • Vanden Berghe, W., Francesconi, E., De Bosscher, K., Rèsche-Rigon, M. and Haegeman, G. (1999b). Dissociated lucocorticoids with Antiinflammatory Potential Repress Interleukin-6 Gene Expression by an NF-kappa-B-Dependent Mechanism. Mol Pharmacol 56, 797-806.

  • Wagner, B. L., Norris, J. D., Knotts, T. A., Weigel, N. L. and McDonnell, D. P. (1998). The nuclear corepressors NCoR and SMRT are key regulators of both ligand-and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol Cell Biol 18, 1369-78.

  • Wang, H., Huang, Z. Q., Xia, L., Feng, Q., Erdjument-Bromage, H., Strahl, B. D., Briggs, S. D., Allis, C. D., Wong, J., Tempst, P. and Zhang, Y. (2001). Methylation of Histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptors. Science 293, 853-857.

  • Wissink, S., van Heerde, E. C., Schmitz, M. L., Kalkhoven, E., van der Burg, B., Baeuerle, P. A. and van der Saag, P. T. (1997). Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. J Biol Chem 272, 22278-84.

  • Wissink, S., van Heerde, E. C., vand der Burg, B. and van der Saag, P. T. (1998). A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids. Mol Endocrinol 12, 355-63.

  • Wolffe, A. and Pruss, D. (1996). Targeting chromatin disruption: transcription regulators that acetylate histones. Cell 84, 817-819.

  • Wolffe, A. P. (1997). Transcriptional control. Sinful repression. Nature 387, 16-7.

  • Wolffe, A. P., wong, J. and Pruss, D. (1997). Activators and repressors: making use of chromatin to regulate transciption. Genes to Cells 2, 291-302.

  • Xu, J., Qiu, Y., DeMayo, F. J., Tsai, S., Tsai, M. and O'Malley, B. W. (1998). Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279, 1922-1925.

  • Xu, L., Glass, C. K. and Rosenfeld, M. G. (1999). Coactivator and corepressor complexes in nuclear receptor function. Curr Op Gen Dev 9, 140-147.

  • Young, J. D., Lawrence, A. J., MacLean, A. G., Leung, B. P., McInnes, I. B., Canas, B., Pappin, D. J. C. and Stevenson, R. D. (1999). Thymosin beta sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nature Med 5, 1424-1427.

  • Zhang, X., Jeyakumar, M., Petukhov, S. and Bagchi, M. K. (1998). A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Mol Endocrinol 12, 513-24.

  • Zhong, H., Voll, R. E. and Ghosh, S. (1998). Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1, 661-671.


Abstract Views: 228

PDF Views: 0




  • Corticosteroids and Way of Inflammation

Abstract Views: 228  |  PDF Views: 0

Authors

Karankumar V. Biradar
R.R.K.College of Pharmacy, Bidar, Karnataka, India
Amit Pawar
K.L.E. College of Pharmacy, Hubli, Karnataka, India

Abstract


No Abstract.

References